03Apr/14

Bayer Initiates Xofigo Combination Study – Analyst Blog – NASDAQ

Bayer Initiates Xofigo Combination Study – Analyst Blog
NASDAQ
The study will evaluate the effects of Xofigo in combination with Johnson & Johnson ‘s ( JNJ ) Zytiga (abiraterone acetate) and prednisone/prednisolone on symptomatic skeletal event-free survival. We note that Xofigo is already approved in the EU for
Bayer HealthCare begins new prostate cancer drug trialZenopa

all 3 news articles »

03Apr/14

Memorial Cardiac and Vascular Institute Receives Federal “Green Light” to … – The Herald | HeraldOnline.com (press release)


The Herald | HeraldOnline.com (press release)

Memorial Cardiac and Vascular Institute Receives Federal “Green Light” to
The Herald | HeraldOnline.com (press release)
“This is a momentous occasion for the MCVI team, who has worked diligently to create a program of the caliber required for heart transplantation,” said Richard Perryman, MD, medical director, MCVI. “We also believe it’s great news for the South Florida …

and more »

03Apr/14

Memorial Cardiac and Vascular Institute Receives Federal “Green Light” to … – Business Wire (press release)


Business Wire (press release)

Memorial Cardiac and Vascular Institute Receives Federal “Green Light” to
Business Wire (press release)
“This is a momentous occasion for the MCVI team, who has worked diligently to create a program of the caliber required for heart transplantation,” said Richard Perryman, MD, medical director, MCVI. “We also believe it’s great news for the South Florida …

and more »